freedom has been researched along with fingolimod hydrochloride in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aschmann, HE; Kesselring, J; Puhan, MA; Spanu, A | 1 |
1 trial(s) available for freedom and fingolimod hydrochloride
| Article | Year |
|---|---|
Benefit-harm balance of fingolimod in patients with MS: A modelling study based on FREEDOMS.
Topics: Fingolimod Hydrochloride; Freedom; Humans; Immunosuppressive Agents; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting | 2020 |